2-237336320-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004369.4(COL6A3):​c.8780T>C​(p.Met2927Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.64 in 1,613,978 control chromosomes in the GnomAD database, including 333,844 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35488 hom., cov: 33)
Exomes 𝑓: 0.64 ( 298356 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 1.38
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2549137E-6).
BP6
Variant 2-237336320-A-G is Benign according to our data. Variant chr2-237336320-A-G is described in ClinVar as [Benign]. Clinvar id is 95008.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-237336320-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.771 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.8780T>C p.Met2927Thr missense_variant Exon 40 of 44 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.8162T>C p.Met2721Thr missense_variant Exon 39 of 43 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.6959T>C p.Met2320Thr missense_variant Exon 37 of 41 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.8780T>C p.Met2927Thr missense_variant Exon 40 of 44 1 NM_004369.4 ENSP00000295550.4 P12111-1

Frequencies

GnomAD3 genomes
AF:
0.678
AC:
103129
AN:
152028
Hom.:
35463
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.778
Gnomad AMI
AF:
0.776
Gnomad AMR
AF:
0.591
Gnomad ASJ
AF:
0.738
Gnomad EAS
AF:
0.536
Gnomad SAS
AF:
0.549
Gnomad FIN
AF:
0.720
Gnomad MID
AF:
0.778
Gnomad NFE
AF:
0.645
Gnomad OTH
AF:
0.694
GnomAD3 exomes
AF:
0.631
AC:
158412
AN:
251020
Hom.:
50943
AF XY:
0.632
AC XY:
85764
AN XY:
135788
show subpopulations
Gnomad AFR exome
AF:
0.782
Gnomad AMR exome
AF:
0.524
Gnomad ASJ exome
AF:
0.724
Gnomad EAS exome
AF:
0.532
Gnomad SAS exome
AF:
0.554
Gnomad FIN exome
AF:
0.714
Gnomad NFE exome
AF:
0.653
Gnomad OTH exome
AF:
0.660
GnomAD4 exome
AF:
0.636
AC:
930432
AN:
1461832
Hom.:
298356
Cov.:
78
AF XY:
0.634
AC XY:
461244
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.788
Gnomad4 AMR exome
AF:
0.534
Gnomad4 ASJ exome
AF:
0.731
Gnomad4 EAS exome
AF:
0.567
Gnomad4 SAS exome
AF:
0.554
Gnomad4 FIN exome
AF:
0.705
Gnomad4 NFE exome
AF:
0.638
Gnomad4 OTH exome
AF:
0.645
GnomAD4 genome
AF:
0.678
AC:
103196
AN:
152146
Hom.:
35488
Cov.:
33
AF XY:
0.678
AC XY:
50390
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.778
Gnomad4 AMR
AF:
0.591
Gnomad4 ASJ
AF:
0.738
Gnomad4 EAS
AF:
0.536
Gnomad4 SAS
AF:
0.548
Gnomad4 FIN
AF:
0.720
Gnomad4 NFE
AF:
0.645
Gnomad4 OTH
AF:
0.689
Alfa
AF:
0.654
Hom.:
81626
Bravo
AF:
0.675
TwinsUK
AF:
0.652
AC:
2419
ALSPAC
AF:
0.641
AC:
2469
ESP6500AA
AF:
0.780
AC:
3437
ESP6500EA
AF:
0.654
AC:
5621
ExAC
AF:
0.638
AC:
77488
Asia WGS
AF:
0.557
AC:
1940
AN:
3478
EpiCase
AF:
0.657
EpiControl
AF:
0.661

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 05, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 04, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 80% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 74. Only high quality variants are reported. -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Bethlem myopathy 1A Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dystonia 27 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Ullrich congenital muscular dystrophy 1A Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
1.7
DANN
Benign
0.28
DEOGEN2
Benign
0.13
.;T;.;T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0012
N
LIST_S2
Benign
0.034
T;T;T;T;.
MetaRNN
Benign
0.0000013
T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-1.9
.;N;.;.;.
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.0
N;N;N;.;N
REVEL
Benign
0.16
Sift
Benign
1.0
T;T;T;.;T
Sift4G
Benign
0.66
T;T;T;T;T
Polyphen
0.0
B;B;.;.;B
Vest4
0.0090
MPC
0.17
ClinPred
0.00058
T
GERP RS
2.2
Varity_R
0.037
gMVP
0.058

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6728818; hg19: chr2-238244963; COSMIC: COSV55081834; COSMIC: COSV55081834; API